Entity Public Float of ABVC BIOPHARMA, INC. from 31 Jan 2012 to 30 Jun 2024

Taxonomy & unit
dei: USD
Description
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary
ABVC BIOPHARMA, INC. quarterly Entity Public Float in USD history and change rate from 31 Jan 2012 to 30 Jun 2024.
  • ABVC BIOPHARMA, INC. Entity Public Float for the quarter ending 30 Jun 2024 was $7,200,000, a 38% increase year-over-year.
Source SEC data
View on sec.gov
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Change (%)

ABVC BIOPHARMA, INC. Quarterly Entity Public Float (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $7,200,000 +$2,000,000 +38% 30 Jun 2024 10-K 15 Apr 2025 2024 FY
Q2 2023 $5,200,000 -$13,651,957 -72% 30 Jun 2023 10-K/A 15 Mar 2024 2023 FY
Q2 2022 $18,851,957 +$2,363,584 +14% 30 Jun 2022 10-K 31 Mar 2023 2022 FY
Q2 2021 $16,488,373 -$56,773,205 -77% 30 Jun 2021 10-K/A 06 Jun 2022 2021 FY
Q2 2020 $73,261,578 30 Jun 2020 10-K 16 Mar 2021 2020 FY
Q2 2018 $58,434,504 -$11,489,802 -16% 29 Jun 2018 10-K 15 May 2020 2019 FY
Q2 2017 $69,924,306 30 Jun 2017 10-KT 13 Apr 2018 2017 FY
Q1 2017 $69,924,306 +$34,730,410 +99% 31 Mar 2017 10-K 16 Jan 2018 2017 FY
Q1 2016 $35,193,896 +$35,193,896 31 Mar 2016 10-K/A 22 Sep 2017 2016 FY
Q1 2015 $0 31 Mar 2015 10-K 27 Nov 2015 2015 FY
Q4 2014 $545,930 31 Dec 2014 10-K 16 Apr 2015 2013 FY
Q2 2014 $818,895 30 Jun 2014 10-K 17 Apr 2015 2014 FY
Q4 2011 $1,175,895 31 Jan 2012 10-Q 15 May 2012 2012 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.